Logo Image
News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gallbladder Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Mesothelioma
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
    • Small Lymphocytic Lymphoma (SLL)
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Advanced Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement

Jane Loeb Rubin

Advertisement

Articles by Jane Loeb Rubin

rubin

Former Hospital Executive on Risks Patients With Cancer Face After Discharge

ByJane Loeb Rubin,Kaitlyn M. Le
October 3rd 2026

After 17 and a half years with metastatic primary peritoneal cancer, a former hospital executive explains how an AI health agent helped her after discharge.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on CURE

    1

    Radiation Oncologist Answers Top Questions About Radiation Therapy

    2

    5 Years of Breast Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients

    3

    FDA Approves Jaypirca as First-Line Treatment for CLL and SLL

    4

    Shorter Radiation After Prostate Surgery Controlled Cancer as Well at 5 Years, With a Trade-Off

    5

    Giredestrant Combo Cuts Progression Risk by 44% in Advanced Breast Cancer

    • About Us
    • Advertise / Support
    • Editorial Board
    • Contact Us
    • CancerNetwork.com
    • TargetedOnc.com
    • OncLive.com
    • OncNursingNews.com
    • Terms & Conditions
    • Privacy
    • Do Not Sell My Information
    • Washington My Health My Data
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.